Skip to main content

Valneva: Coronavirus

Question for Department for Business, Energy and Industrial Strategy

UIN 125512, tabled on 18 February 2022

To ask the Secretary of State for Business, Energy and Industrial Strategy, for what reason the Government cancelled its contract with Valneva for their covid-19 vaccine.

Answered on

28 February 2022

As any responsible Government does, we manage our vaccine supply to meet our projected needs and to offer the best protection to those who need it, when they need it. The termination of the supply agreement with Valneva in September 2021 was made for commercial reasons, which remain confidential between Valneva and the Government.

Vaccine development is a complex and challenging process, which is why the Government seeks to achieve value for money for the UK taxpayer at all stages. As the pandemic progresses, we continue to assess and refine the vaccines in our portfolio, to ensure we continue to have access to those which offer the best long-term prospects in continuing to support the fight against Covid-19.

Thanks to this strategy, the UK currently has 3 approved vaccines in deployment and the UK’s vaccination programme continues to be a success with over 85% of the UK population [over 12s] double vaccinated and over 66% of the UK population [over 12s] have now received their booster or third dose of a Covid-19 vaccine.